Pharma Journalist -

Endo International plc announced that its subsidiary Endo Ventures Limited has entered into agreements with Quoin Pharmaceuticals Inc. for the development, registration, supply,…
Read More...

SAE Media Group reports: The 5th Annual Ophthalmic Drugs Conference is set to return in November 2022 with a key focus on drug delivery and gene therapy. SAE Media Group is delighted…
Read More...

NeoImmuneTech, Inc. (NIT) announced that the U.S. Food and Drug Administration (FDA) has granted NT-I7 (efineptakin alfa) (rhIL-7-hyFc) Orphan Drug Designation for the treatment of…
Read More...

SK Biopharmaceuticals, Co., Ltd., announced that it has entered into a licensing agreement for Eurofarma, a Brazilian pharmaceutical company with business in over 20 countries, to…
Read More...

Zymergen Inc. announced it has expanded its agreement with Octant to further scale their next-generation platform to develop breakthrough medicines. In May, Octant purchased five…
Read More...

Today, Health Canada authorized the use of the Moderna Spikevax COVID-19 vaccine in children 6 months to 5 years of age. This is the first COVID-19 vaccine authorized in Canada for use…
Read More...

Codexis, Inc. announced that the Company has entered into an agreement with Pfizer for the supply of a proprietary high-performance enzyme used to manufacture a critical intermediate…
Read More...

Labcorp announced the launch of the first widely accessible test that provides direct evidence of neurodegeneration and neuronal injury. The new Neurofilament Light Chain…
Read More...

Orion Corporation and MSD announced a global development and commercialisation agreement for Orion’s investigational candidate ODM-208 and other drugs targeting cytochrome P450 11A1…
Read More...

Novavax, Inc. announced that the Novavax COVID-19 Vaccine, Adjuvanted (NVX-CoV2373) has received emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA) to…
Read More...